摘要：向幸福出发...

步步惊心

8月以来碳酸锂期货涨了10余天后市怎么走_我的网站

一 | Influenza and other respiratory viruses are starting to circulate but so far remain lower than this time last year, according to the Centers for Disease Control and Prevention.As of Oct. 7, CDC's FluView weekly report showed that the percent of flu cases were relatively unchanged, rising about 1% compared to the week prior.In that same timeframe, 1,127 people were hospitalized with influenza, up from 1,050 people the week prior. About 35% of all flu hospitalizations were reported in the southeast of the U.S., which experts say is a typical trend at the start of the flu season.Most of the flu cases detected were Influenza A and the most common subtype was Influenza A(H1N1), which is the strain of the virus that the flu vaccine usually offers better protection from, according to the CDC.The percent of all reported respiratory viruses circulating over the past week have been relatively unchanged nationally, but there is regional variability. Region 9 -- made up of Arizona, California, Hawaii, and Nevada -- was the only region that saw an increase.Still, the numbers in all regions of the U.S. remain below their baseline and outpatient respiratory illness activity is either minimal or low throughout most of the U.S., according to the CDC.Alaska is the only state that is currently experiencing moderate respiratory illness activity. Influenza typically circulates this time of year and peaks between December and February for most of the U.S., according to the CDC.Respiratory syncytial virus (RSV) numbers are on the rise and are projected to increase further, according to the CDC's weekly surveillance. RSV typically circulates from October to April, according to the CDC.

How to prepare for this year's cold and flu season

This time last year, the U.S. was bracing for a "tripledemic" amid rising cases of COVID-19, influenza and RSV after the seasons became more unpredictable during the COVID-19 pandemic.Dr. John Brownstein, chief innovation officer at Boston Children's Hospital and an ABC News contributor, said these early cases are behaving in a more predictable pattern."The data is pointing to something a little bit more par for the course. We're seeing the early rise of RSV and flu at a time when you'd expect it," Brownstein said.Brownstein, however, cautioned that cases of respiratory viruses are expected to increase further and higher levels still have potential to strain health systems and cause severe illnesses, Brownstein said."I think there's still concern around the threat of all three respiratory viruses plus, of course, the rest of the seasonal mix [of viral illnesses], wreaking havoc on our health systems," he said.Experts are hopeful that new and updated immunizations that protect against COVID-19, influenza and RSV will stave off the strain on health care systems.These viruses may only cause mild illness for many people, but young babies, pregnant women, people who are immunocompromised and the elderly are at highest risk for severe disease.Everyone 6 months and older is eligible for an updated COVID-19 shot and the annual flu vaccine.The Department of Health and Human Services told ABC News that, so far, more than 7 million updated COVID-19 shots have been administered. The CDC recommends getting the COVID-19 and flu vaccines by the end of October and encourages both to be given at the same time.Adults who are 60 years and older can get an RSV vaccine and pregnant women who are in their third trimester can get an RSV shot that provides protection against RSV to their baby for the first 6 months of life.Babies less than 8 months old who are born to mothers who did not get an RSV vaccine during pregnancy can get a protective shot called nirsevimab that offers about five months of protection against RSV.Nirsevimab is a one-dose shot made of monoclonal antibodies, which are proteins manufactured in a lab and mimic the antibodies the body naturally creates when fighting an infection. This is different than a vaccine, which activates the immune system.Brownstein said the pandemic has helped make many health systems better prepared for seasonal spikes in respiratory viruses and is hopeful that people are more motivated to stay up to date on shots that are available for protection and prevention this respiratory virus season."Now is really the time to get the protection advanced of the seasons really heating up," Brownstein said.Dr. Jade A Cobern, M.D., M.P.H, a licensed and practicing physician, is a member of the ABC News Medical Unit.。 K图 lcm_0

　　进入8月以来，碳酸锂期货走出一轮明显反弹行情，价格从135000元/吨附近，上涨至当前的近160000元/吨。

二 | 当前，主力合约也从LC2609合约切换至LC2701合约。

三 | 截至8月21日收盘，LC2701合约价格报收158680元/吨，单日涨幅为4.12%。
　　业内人士认为，本轮碳酸锂价格反弹是宏观情绪与产业基本面共振的表现。

四 | 当前来看，碳酸锂市场仍处于基本面“强现实”与远期供应宽松“弱预期”的博弈窗口，短期碳酸锂价格或受库存大幅去化、需求支撑等因素影响呈现偏强运行态势，但中长期来看，上行空间或仍受供给恢复等因素制约。　　创元期货分析师余烁认为，基本面持续向好是本轮碳酸锂价格走强的直接支撑。供应方面，锂精矿进口环比下降不及预期，津巴布韦出口政策影响仍在延续。数据显示，7月津巴布韦锂精矿进口量下滑至2.2万吨，环比下降48%，国内部分锂盐厂因缺矿而检修，供给端增量受限。需求方面，余烁表示，下游需求即将迎来“金九银十”传统旺季，9月排产预期向好，考虑到国内检修企业复产带来的供给增量，后续去库幅度收窄但绝对值仍然偏高。

五 | 下游企业在经历两个月去库后，库存水平偏低，旺季前或有补库需求。

六 | 余烁表示，本周碳酸锂基差走强，部分高品质现货报价平水LC2609合约价格。　　据银河期货分析师陈婧介绍，今年8月，电池厂排产环比增长7%～9%，正极材料厂排产环比增长5%～6%。“由于正极材料新增产能爬产慢于预期，原有产线订单增加，8月份部分企业上修排产数据，需求端旺季特征超预期，而供应端受津巴布韦锂精矿回流偏慢、江西大矿再次停产、外采锂矿成本偏高等因素影响。”陈婧解释称，当前供应增速难以匹配需求增速，预计8月供需缺口将持续扩大，库存加速去化。据SMM数据，截至8月20日当周，碳酸锂周度大样本库存去化7516吨，至86392吨，去库幅度持续扩大。　　陈婧认为，宏观环境变化同样给碳酸锂市场提供情绪支撑。“7月30日美联储会议释放不加息信号，市场流动性预期转向，整体风险偏好修复，股市与大宗商品同步反弹，对碳酸锂盘面形成情绪层面的提振，叠加产业端的实质性改善，共同促成这一轮价格修复。”陈婧解释称。　　值得关注的是，近期市场高度关注江西枧下窝锂矿的复产进展，这一矿山相关证件的审批节奏，仍在深刻影响市场对远期供给的判断。据悉，宜春市生态环境局于8月17日公布“拟受理枧下窝锂矿采矿项目环境影响评价”相关文件。文件显示，本项目采矿规模为 3000万吨/年。在项目停产前，宁德时代枧下窝项目的采矿规模为 4500万吨/年陶瓷土（含锂）。本次环评下调采矿规模，引发市场较大关注。　　“矿山生产需要采矿证、安全生产许可证两个重要证件。

七 | 此前枧下窝采矿证规模为4500万吨/年，安全生产许可证开采规模为3000万吨/年，安全生产许可证于今年6月26日变更后维持3000万吨/年。此次环评下调采矿规模，与安全生产许可证保持一致，理论上完全复产后前后可开采规模不变，均为3000万吨/年。

八 | ”余烁解释称。　　余烁认为，枧下窝锂矿的“供应量”并未有实质性变量，该项目的矛盾核心在于“复产节奏”，而非“开采规模”，市场更为关注的是枧下窝矿山何时复产。8月28日环评公示结束之后，正式批复最快或要等到9月中旬。本次环评仅覆盖采矿环节，选矿环节能否同步顺利推进依旧存在不确定性，整体进度大概率会低于市场此前9月复产的乐观预期。